100 related articles for article (PubMed ID: 28106922)
61. Risk of venous thromboembolism in children after general surgery.
Humes DJ; Nordenskjöld A; Walker AJ; West J; Ludvigsson JF
J Pediatr Surg; 2015 Nov; 50(11):1870-3. PubMed ID: 26078211
[TBL] [Abstract][Full Text] [Related]
62. Type 1 diabetes is associated with an increased risk of venous thromboembolism: A retrospective population-based cohort study.
Peng YH; Lin YS; Chen CH; Tsai KY; Hung YC; Chen HJ; Liao WC; Ho WC
PLoS One; 2020; 15(1):e0226997. PubMed ID: 31935226
[TBL] [Abstract][Full Text] [Related]
63. Taller women are at greater risk of recurrent venous thromboembolism: the Iowa Women's Health Study.
Lutsey PL; Folsom AR
Am J Hematol; 2012 Jul; 87(7):716-7. PubMed ID: 22488550
[TBL] [Abstract][Full Text] [Related]
64. The incidence of first venous thromboembolism in and around pregnancy using linked primary and secondary care data: a population based cohort study from England and comparative meta-analysis.
Abdul Sultan A; Tata LJ; Grainge MJ; West J
PLoS One; 2013; 8(7):e70310. PubMed ID: 23922975
[TBL] [Abstract][Full Text] [Related]
65. Hormonal contraceptive use after a first venous thrombotic event and the risk of recurrence in premenopausal women.
Verlaan JPL; Stegeman BH; Timp JF; Scheres LJJ; Flinterman LE; Helmerhorst FM; Rosendaal FR; Cannegieter SC; van Hylckama Vlieg A
J Thromb Haemost; 2024 Mar; ():. PubMed ID: 38554933
[TBL] [Abstract][Full Text] [Related]
66. Impact of risk factors on the timing of first postpartum venous thromboembolism: a population-based cohort study from England.
Abdul Sultan A; Grainge MJ; West J; Fleming KM; Nelson-Piercy C; Tata LJ
Blood; 2014 Oct; 124(18):2872-80. PubMed ID: 25157182
[TBL] [Abstract][Full Text] [Related]
67. Venous thromboembolism and hormone replacement therapy.
Mannucci PM
Eur J Intern Med; 2001 Dec; 12(6):478-83. PubMed ID: 11711269
[TBL] [Abstract][Full Text] [Related]
68. Hormone replacement therapy: changes in prescribing practice.
Davies M; Hamoda H;
BMJ; 2019 Feb; 364():l633. PubMed ID: 30745316
[No Abstract] [Full Text] [Related]
69. Using case-control studies for prescribing research.
Mant J; Vessey M
J Clin Pharm Ther; 2002 Feb; 27(1):67-74. PubMed ID: 11846863
[TBL] [Abstract][Full Text] [Related]
70. Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases.
BMJ; 2019 Jan; 364():l162. PubMed ID: 30647094
[No Abstract] [Full Text] [Related]
71. Drospirenone-Containing Oral Contraceptive Pills and the Risk of Venous Thromboembolism: An Assessment of Risk in First-Time Users and Restarters.
Larivée N; Suissa S; Coulombe J; Tagalakis V; Filion KB
Drug Saf; 2017 Jul; 40(7):583-596. PubMed ID: 28382493
[TBL] [Abstract][Full Text] [Related]
72. Risk prediction of developing venous thrombosis in combined oral contraceptive users.
McDaid A; Logette E; Buchillier V; Muriset M; Suchon P; Pache TD; Tanackovic G; Kutalik Z; Michaud J
PLoS One; 2017; 12(7):e0182041. PubMed ID: 28750087
[TBL] [Abstract][Full Text] [Related]
73. Risk of recurrence in women with venous thromboembolism related to estrogen-containing contraceptives: Systematic review and meta-analysis.
Wiegers HMG; Knijp J; van Es N; Coppens M; Moll S; Klok FA; Middeldorp S
J Thromb Haemost; 2022 May; 20(5):1158-1165. PubMed ID: 35108438
[TBL] [Abstract][Full Text] [Related]
74. Optimal follow-up after acute pulmonary embolism: a position paper of the European Society of Cardiology Working Group on Pulmonary Circulation and Right Ventricular Function, in collaboration with the European Society of Cardiology Working Group on Atherosclerosis and Vascular Biology, endorsed by the European Respiratory Society.
Klok FA; Ageno W; Ay C; Bäck M; Barco S; Bertoletti L; Becattini C; Carlsen J; Delcroix M; van Es N; Huisman MV; Jara-Palomares L; Konstantinides S; Lang I; Meyer G; Ní Áinle F; Rosenkranz S; Pruszczyk P
Eur Heart J; 2022 Jan; 43(3):183-189. PubMed ID: 34875048
[TBL] [Abstract][Full Text] [Related]
75. Which patients are at high risk of recurrent venous thromboembolism (deep vein thrombosis and pulmonary embolism)?
Áinle FN; Kevane B
Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):201-212. PubMed ID: 33275736
[TBL] [Abstract][Full Text] [Related]
76. Which patients are at high risk of recurrent venous thromboembolism (deep vein thrombosis and pulmonary embolism)?
Áinle FN; Kevane B
Blood Adv; 2020 Nov; 4(21):5595-5606. PubMed ID: 33170937
[TBL] [Abstract][Full Text] [Related]
77. Recurrence risk of venous thromboembolism and hormone use in women from England: a cohort study using clinical practice research datalink.
Kiconco S; Abdul Sultan A; Grainge MJ
Br J Haematol; 2017 Apr; 177(1):127-135. PubMed ID: 28106922
[TBL] [Abstract][Full Text] [Related]
78. Hormone therapy and risk of venous thromboembolism among postmenopausal women in Taiwan - a 10-year nationwide population-based study.
Lee CH; Cheng CL; Kao Yang YH; Lin LJ
Circ J; 2015; 79(5):1107-14. PubMed ID: 25753572
[TBL] [Abstract][Full Text] [Related]
79. Risk factors for recurrent venous thromboembolism in young and middle-aged women.
Ljungqvist M; Sonnevi K; Bergendal A; Holmström M; Kieler H; Lärfars G
Thromb Res; 2014 May; 133(5):762-7. PubMed ID: 24613699
[TBL] [Abstract][Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
